Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CoheSIL to enter silicone breast implant trial:

This article was originally published in Clinica

Executive Summary

McGhan Medical, of Santa Barbara, California, is to begin a multicentre US trial of its new silicone breast implant, CoheSIL. The implant is made of cohesive silicone gel and is encased in a silicone shell that is more durable than previous models. The shell is also designed to hold its shape better than the current saline implants. Around half of the 940 patients in the trial will undergo augmentation and the remainder reconstruction or revision surgery. Safety concerns in the 1980s prompted litigation regarding silicone breast implants, and eventually led to their withdrawal for use in routine breast augmentation in the US.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts